Mid-Day Market Update: Crude Oil Surges 3%; Revelation Biosciences Shares Plunge
U.S. stocks traded lower midway through trading following the release of GDP data.
35 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares jumped 82.6% to $4.71 after the company reported a year over year increase in Q4 sales results and issued Q1 sales guidance above analyst estimates.
12 Health Care Stocks Moving In Wednesday’s Pre-Market Session
Gainers
Adagio Therapeutics (NASDAQ:ADGI) shares increased by 52.2% to $5.86 during Wednesday's pre-market session. The company's market cap stands at $651.9 million.
HC Wainwright & Co. Maintains Buy on Vir Biotechnology, Lowers Price Target to $200
HC Wainwright & Co. analyst Patrick Trucchio maintains Vir Biotechnology (NASDAQ:VIR) with a Buy and lowers the price target from $300 to $200.
Needham Maintains Buy on Vir Biotechnology, Lowers Price Target to $45
Needham analyst Joseph Stringer maintains Vir Biotechnology (NASDAQ:VIR) with a Buy and lowers the price target from $80 to $45.
64 Biggest Movers From Friday
Gainers
Clever Leaves Holdings Inc. (NASDAQ: CLVR) shares surged 143% to settle at $3.84 on Friday after the company reported better-than-expected Q4 sales results and reaffirmed FY22 guidance.
Drug makers, Scientists Working For Long COVID Treatments: Reuters
Researchers and drugmakers, including those who have launched antiviral pills and monoclonal antibodies for COVID-19, are having early discussions about targeting Long COVID,
GSK/Vir Biotech’s COVID-19 Antibody Associated With Resistance Mutations, New Research Shows
According to new research in Australia, some people have developed sotrovimab-resistant mutations following infusions with the GlaxoSmithKline Plc (NYSE:GSK) and Vir Biotechnology Inc (NASDAQ:VIR)…